
Kathleen Kerr Bragdon
Supervisory Patent Examiner (ID: 13795, Phone: (571)272-0931 , Office: P/1600 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652, 1646, 1656 |
| Total Applications | 355 |
| Issued Applications | 183 |
| Pending Applications | 50 |
| Abandoned Applications | 122 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18391266
[patent_doc_number] => 20230159484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => FLUORESCENT DYES HAVING HIGH STOKES SHIFT, ON THE BASIS OF BRIDGED BENZOPYRYLIUM SALTS
[patent_app_type] => utility
[patent_app_number] => 17/995356
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11169
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 749
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995356
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995356 | FLUORESCENT DYES HAVING HIGH STOKES SHIFT, ON THE BASIS OF BRIDGED BENZOPYRYLIUM SALTS | Mar 31, 2021 | Pending |
Array
(
[id] => 17258688
[patent_doc_number] => 20210371673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => COATED BODY AND COATING COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/214118
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214118
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214118 | COATED BODY AND COATING COMPOSITION | Mar 25, 2021 | Abandoned |
Array
(
[id] => 16990124
[patent_doc_number] => 20210228544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/208676
[patent_app_country] => US
[patent_app_date] => 2021-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9837
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 213
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/208676 | Formulation for soft anticholinergic analogs | Mar 21, 2021 | Issued |
Array
(
[id] => 17110219
[patent_doc_number] => 20210290816
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => LIQUID EMBOLICS
[patent_app_type] => utility
[patent_app_number] => 17/204581
[patent_app_country] => US
[patent_app_date] => 2021-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204581
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/204581 | LIQUID EMBOLICS | Mar 16, 2021 | Abandoned |
Array
(
[id] => 16932306
[patent_doc_number] => 20210198195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => FORMULATION FOR SOFT ANTICHOLINERGIC ANALOGS
[patent_app_type] => utility
[patent_app_number] => 17/202063
[patent_app_country] => US
[patent_app_date] => 2021-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17202063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/202063 | Formulation for soft anticholinergic analogs | Mar 14, 2021 | Issued |
Array
(
[id] => 16932521
[patent_doc_number] => 20210198410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => NOVEL BLOCK COPOLYMER AND MICELLE COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/198006
[patent_app_country] => US
[patent_app_date] => 2021-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17352
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198006
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198006 | Block copolymer and micelle compositions and methods of use thereof | Mar 9, 2021 | Issued |
Array
(
[id] => 17727714
[patent_doc_number] => 11384088
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Radiopharmaceuticals, radioimaging agents, and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/198131
[patent_app_country] => US
[patent_app_date] => 2021-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 9830
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198131
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198131 | Radiopharmaceuticals, radioimaging agents, and uses thereof | Mar 9, 2021 | Issued |
Array
(
[id] => 18497316
[patent_doc_number] => 20230219933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => STERICALLY SHIELDED HEPTAMETHINE CYANINE DYES
[patent_app_type] => utility
[patent_app_number] => 17/996420
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16124
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996420
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996420 | Sterically shielded heptamethine cyanine dyes | Feb 21, 2021 | Issued |
Array
(
[id] => 18012065
[patent_doc_number] => 11504339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Compositions comprising urolithin a and uses thereof in treating kidney injury
[patent_app_type] => utility
[patent_app_number] => 17/160836
[patent_app_country] => US
[patent_app_date] => 2021-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 16022
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17160836
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/160836 | Compositions comprising urolithin a and uses thereof in treating kidney injury | Jan 27, 2021 | Issued |
Array
(
[id] => 17759970
[patent_doc_number] => 20220233582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => Silicone Face Mask For Skin Treatment
[patent_app_type] => utility
[patent_app_number] => 17/156619
[patent_app_country] => US
[patent_app_date] => 2021-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17156619
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/156619 | Silicone Face Mask For Skin Treatment | Jan 23, 2021 | Abandoned |
Array
(
[id] => 18279130
[patent_doc_number] => 20230094602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => NOVEL GADOLINIUM-BASED COMPOUND, PREPARATION METHOD THEREFOR, AND MRI CONTRAST AGENT CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/794807
[patent_app_country] => US
[patent_app_date] => 2021-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3742
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17794807
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/794807 | Gadolinium-based compound, preparation method therefor, and MRI contrast agent containing same | Jan 21, 2021 | Issued |
Array
(
[id] => 18319699
[patent_doc_number] => 20230117827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => COMPOSITION COMPRISING A FLUOROPHORE LABELLED UPAR-TARGETING PEPTIDE CONJUGATE
[patent_app_type] => utility
[patent_app_number] => 17/792336
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17792336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/792336 | COMPOSITION COMPRISING A FLUOROPHORE LABELLED UPAR-TARGETING PEPTIDE CONJUGATE | Jan 14, 2021 | Pending |
Array
(
[id] => 17005499
[patent_doc_number] => 20210236660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-05
[patent_title] => IMAGEABLE POLYMERS
[patent_app_type] => utility
[patent_app_number] => 17/150310
[patent_app_country] => US
[patent_app_date] => 2021-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11562
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/150310 | IMAGEABLE POLYMERS | Jan 14, 2021 | Pending |
Array
(
[id] => 17702604
[patent_doc_number] => 20220202610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => CONTACT LENS WITH SUSTAINED RELEASE PROPERTY
[patent_app_type] => utility
[patent_app_number] => 17/139360
[patent_app_country] => US
[patent_app_date] => 2020-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5143
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17139360
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/139360 | CONTACT LENS WITH SUSTAINED RELEASE PROPERTY | Dec 30, 2020 | Abandoned |
Array
(
[id] => 16778190
[patent_doc_number] => 20210115268
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => FUNCTIONALIZED QUATERNARY AMMONIUM HALIDES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/137564
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8173
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17137564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/137564 | FUNCTIONALIZED QUATERNARY AMMONIUM HALIDES AND USE THEREOF | Dec 29, 2020 | Abandoned |
Array
(
[id] => 18280235
[patent_doc_number] => 20230095707
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => MULTIMODAL FLUORINE-CY3/5/7-DOTA-HAPTEN COMPOSITIONS, DIAGNOSTICS, FLUORESCENCE GUIDED SURGERY AND RADIOIMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/790079
[patent_app_country] => US
[patent_app_date] => 2020-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790079
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790079 | Multimodal fluorine-CY3/5/7-DOTA-hapten compositions, diagnostics, fluorescence guided surgery and radioimmunotherapy | Dec 29, 2020 | Issued |
Array
(
[id] => 16762354
[patent_doc_number] => 20210107935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => NOVEL, HEAVY VITAMIN B12 DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/128511
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5847
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17128511
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/128511 | Heavy vitamin B12 derivatives | Dec 20, 2020 | Issued |
Array
(
[id] => 18282966
[patent_doc_number] => 20230098438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/790698
[patent_app_country] => US
[patent_app_date] => 2020-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19218
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17790698
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/790698 | OXAZINE-BASED WATER-SOLUBLE FLUOROPHORE COMPOUNDS FOR IN VIVO NERVE IMAGING | Dec 20, 2020 | Pending |
Array
(
[id] => 18159274
[patent_doc_number] => 20230025866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/787545
[patent_app_country] => US
[patent_app_date] => 2020-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5324
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17787545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/787545 | NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES | Dec 17, 2020 | Pending |
Array
(
[id] => 18309058
[patent_doc_number] => 20230112958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => Smart Drug Delivery System and Pharmaceutical Kit for Dual Nuclear Medical Cytotoxic Theranostics
[patent_app_type] => utility
[patent_app_number] => 17/786844
[patent_app_country] => US
[patent_app_date] => 2020-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786844
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/786844 | Smart Drug Delivery System and Pharmaceutical Kit for Dual Nuclear Medical Cytotoxic Theranostics | Dec 16, 2020 | Pending |